‘Unfair’ ESOP Valuations Drive $7M Settlement with EBSA

The recent judgement against AIT Laboratories adds nearly $3.5 million to previous collections, now totaling more than $7 million. 

The U.S. Department of Labor’s Employee Benefits Security Administration (EBSA) has reached a settlement restoring an additional $3.47 million directly to AIT Laboratories Employee Stock Ownership Plan (ESOP), “for losses associated with the plan’s 2009 purchase of overpriced company stock.”

A federal order and judgement from the U.S. District Court for the Southern District of Indiana, Indianapolis, resolves the EBSA lawsuit alleging that the plan’s trustee, PBI Bank Inc., and AIT’s chief executive officer, Michael Evans, violated the Employee Retirement Income Security Act by knowingly overpaying for company stock with ESOP assets.

Want the latest retirement plan adviser news and insights? Sign up for PLANADVISER newsletters.

The alleged violations occurred when PBI authorized the plan’s purchase of AIT Holding Company Inc., stock from Evans and other AIT executives. EBSA says the purchase amount was “far higher than the stock’s fair market value.” 

Combined with two other previous settlements of suits filed by the department, EBSA and its attorneys have recovered approximately $7.1 million in direct monetary relief for the AIT ESOP’s participants and beneficiaries. 

“These settlements restore to workers the stake they have in the company’s success,” says Assistant Secretary of Labor for the Employee Benefits Security Administration Phyllis Borzi. “Too often, we see purchase price manipulation and other schemes that benefit corporate leadership at the expense of employees. This is unjust and unlawful under regulations which protect these investments for employees’ long-term future.”

In addition to direct monetary relief to the plan, the recent order with Evans and PBI directs AIT to issue additional AIT stock to the ESOP, worth approximately $300,000; grants the ESOP a $5.9 million interest in certain properties controlled by Evans; and requires Evans to forgive a portion of his loans to AIT, worth approximately $2.5 million to the ESOP, and to share with the ESOP a portion of any future sale of his AIT stock.

Investigators with the EBSA’s Cincinnati Regional Office conducted the probe that led to the suit. The department’s Office of the Solicitor in Chicago and Washington, D.C. litigated the case.

Additional information can be found at www.dol.gov/ebsa.  

Principal Offers Paper Discussing In-Plan Deferred Annuities

Written by Bruce Ashton of Drinker, Biddle & Reath, the paper discusses how an in-plan deferred income annuity retiree risks, and what steps a plan fiduciary should take to research options and make a prudent decision.

A new white paper from Principal walks through how in-plan deferred income annuities offered within a retirement plan help future retirees manage different risks such as outliving their savings, downturns in the market and changing interest rates.

The paper, written by Bruce Ashton of Drinker Biddle & Reath LLP, discusses longevity, investment, interest rate, withdrawal rate, inflation, cognitive impairment, health care cost and public policy change risks. “The financial services community offers a number of solutions designed to address at least some of these risks. They included professionally managed accounts, payout mutual funds, guaranteed minimum withdrawal benefit (GMWB) accounts, immediate annuities purchased at retirement, “longevity insurance (that is, a type of deferred annuity paid for at retirement under which payments do not begin until the retiree reaches age 80 or 85) and in-plan deferred income annuities. None of these solutions address the last two risks—rising health care costs and public policy changes—but the in-plan deferred income annuity (a DIA) addresses all of the others,” the paper says.

For more stories like this, sign up for the PLANADVISERdash daily newsletter.

“The Retirement Income Dilemma: An In-Plan Solution” discusses how an in-plan deferred income annuity addresses more of these risks than other products available today, and what steps a plan fiduciary should take to research options and make a prudent decision.

The paper is available in condensed and full versions. It also includes checklists for plan sponsors to use when researching different in-plan products and providers.

«